European Society of Cardiology Congress

An international team looked at oral anticoagulants and decided dabigatran is the best for stroke prevention in non-valvular atrial fibrillation.

Percutaneous balloon mitral valvulopasty (PMV) has now been around long enough for long term outcomes to be assessed. The verdict is positive.

Data mining may be a promising method to search for unknown drug-drug interactions in cardiovascular medicine.

Lung cancer patients who develop sinus tachycardia due to some treatments for their cancer can successfully reduce their heart rates with ivabradine, researchers in Romania report.

Emerging more frequently as part of the total evidence generated with Eliquis, real-world data allows researchers to work with larger populations to show specific reductions in major bleeding and stroke, as well.

In the ongoing search for subclinical markers of heart disease, Taiwan researchers found that the diameter of the aortic root is a useful predictor.

Heart failure patients with reduced ejection fraction do better with cardiac interventions, particularly CABG, a meta-analysis of 20 studies found.

Think you should hang up those running shoes after 65? Think again, Finish researchers report. Older people who spent at least 3 hours weekly working up a sweat and high heart rate had fewer heart events.

Pope Francis plans to appear at the ESC Congress 2016 to endorse the group's healthy lifestyle campaign.

Poushali Mukherjea, PhD, Executive Director, Global Medical Affairs, Bristol-Myers Squibb, noted some key takeaways from her team's 19 abstracts slated to be presented at the European Society of Cardiology Congress 2016 (ESC).

It may be the European Society of Cardiology's annual congress, but with abstract submissions from North America and Asia the recent event was further proof that the field is becoming more globalized while still holding to its Localized roots.

Obesity is a growing problem around the world and new research has shown that even small amounts of physical exercise can make a big difference in keeping people from gaining too much weight.

As the European Society of Cardiology wraps up another successful congress in London there remains a buzz about the work being done by doctors around the world to help patients with a variety of conditions.

As oral anticoagulants become more popular and a new generation of the drugs is introduced there are still some questions about the potential risks of taking the medication and whether they outweigh the benefits.

The European Society of Cardiology's annual conference in London highlighted some of the top work being done in the field over the past year.

PCSK9 inhibitors have been the focus of the cardiology community and with the approval of two medications in the past few months these drugs could soon make their way to a large number of patients needing help managing their cholesterol levels using more than just statins.

Congestive heart failure is a serious condition facing people around the world. Early trials of a gene therapy have showed promise to not only help these patients with the condition but also make their hearts healthier.

Just because researchers go into a study with a hypothesis they hope to prove, it does not mean the results will be what they were hoping for.

There is an ever growing list of tests doctors can order for their patients, particularly when it comes to cardiac conditions. Choosing the right test is a very important skill for practitioners to use in their daily practice.

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

On a daily basis cardiologists face patients with a wide variety of conditions. A review of recent studies show just how far the treatment of many of these conditions have come.

If a patient requires bypass surgery one of the factors doctors will look at when considering the operation is the person's blood pressure. A recent study looked at whether it could be safe to operate when the patient's pressure is higher or lower than previously accepted.

When a patient checks into the emergency room, whether on their own or in an ambulance, time is of the essence to make the correct diagnosis. As technology improves so does the ability to make diagnoses in medicine that much faster. This way doctors can treat the patients that need the help the most while the others can be safely discharged and sent home.

Several large groups combined data to look at results of a study on heart failure patients to see whether age and gender affected treatment options prescribed by patients.

While digoxin has been a popular medication in the past, particularly for patients with atrial fibrillation, a recent study looked at whether the medication was indeed beneficial for treatment when compared to placebo or no pharmaceutical therapy at all. Digoxin may be a popular treatment for some patients, but often doctors cannot look at just one condition when treating and have to consider multiple factors and issues.

Treating one patient for an illness can answer some questions for doctors. However, in many cases looking at the larger patient population can answer not only why the patients got sick, but what can be done to keep them healthy in the long run.

With clinical trials becoming more expensive and difficult to arrange in the current medical environment researchers are looking at new ways to test ideas without putting added stress and strain on clinicians.

As value based care becomes a buzz word in the medical industry doctors are learning what it means for their practice and how they can utilize it while still applying the same level of attention to their patients as they did in the past.

A lot has changed in cardiology over time and there is even more change ahead. How doctors handle that change can determine how successful they are in their practice.

As technology improves telemedicine is becoming a more viable option to treat a wide variety of conditions. While the idea of telemedicine can be easily implemented into practice there are still concerns that need to be addressed for the field to progress. These issues can include liability and governance over doctors and where their patients are located.